[Federal Register Volume 69, Number 88 (Thursday, May 6, 2004)]
[Notices]
[Pages 25410-25411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10326]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Sickle Cell Disease Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the contact Person listed below in 
advance of the meeting.

    Name of Committee: Sickle Cell disease Advisory Committee.
    Date: June 7, 2004.
    Time: 8:30 a.m. to 4 p.m.
    Agenda: Discussion of program policies and issues.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Conference Room 9112, Bethesda, MD 20892.
    Contact Person: Charles M. Peterson, MD, Director, Blood 
Diseases Program, Division of Blood Diseases and Resources, National 
Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, room 
10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435-
0080.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS.)


[[Page 25411]]


    Dated: April 29, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-10326 Filed 5-5-04; 8:45 am]
BILLING CODE 4140-01-M